作者: Ami Vyas , Zachary Babcock , Stephen Kogut
DOI: 10.1007/S11764-017-0635-Y
关键词: Public health 、 Antidepressant 、 Multivariate analysis 、 Quality of life 、 Medical Expenditure Panel Survey 、 Depression (differential diagnoses) 、 Psychiatry 、 Medical diagnosis 、 Medicine 、 Cancer
摘要: Cancer diagnosis in adults is often accompanied by negative impacts, which increase the risk of depression thereby lowering health-related quality life (HRQoL). We examined association between treatment and HRQoL among US with cancer depression. Patients age 18 above, self-reported diagnoses were identified from Medical Expenditure Panel Survey database for 2006–2013. Baseline was categorized as antidepressants only, psychotherapy or without antidepressant use, no reported use psychotherapy. measured using SF-12 physical component summary (PCS) mental (MCS) scores. Adjusted ordinary least squares regressions estimated type HRQoL. Out 450 (weighted per calendar year: 2.1 million) included study, 51% received while 16% antidepressants. In bivariate analyses, mean MCS score lowest those who compared to receiving only either modality, p < 0.05. multivariate there significant difference treatment. Despite depression, did not improve during measurement timeframe. Quality a priority health outcome treatment, yet our findings suggest that current clinical approaches ameliorate patients appear be suboptimal. Adults comorbid should receive appropriate care order their